StockData
Amarin Corp PLC logo

Amarin Corp PLC (AMRN) stock

AMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 10/3061% above fair value
$11.26−0.01 (-0.09%)

Close on Nov 18, 2026Market cap $248.90MP/E –Yield –

Amarin revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Amarin's revenue for the twelve months ending Sep 30, 2026 was $176.11M, down 22.3% year over year. For fiscal 2025 it was $213.65M, down 6.5% from the year before. Over ten years it grew 10.1% a year on average. The highest annual figure on record is $614.06M in fiscal 2020.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$213.65M-6.5%
FY2024Dec 31, 2024$228.61M-25.5%
FY2023Dec 31, 2023$306.91M-16.9%
FY2022Dec 31, 2022$369.19M-36.7%
FY2021Dec 31, 2021$583.19M-5.0%
FY2020Dec 31, 2020$614.06M+42.9%
FY2019Dec 31, 2019$429.76M+87.5%
FY2018Dec 31, 2018$229.21M+26.6%
FY2017Dec 31, 2017$181.10M+39.2%
FY2016Dec 31, 2016$130.08M+59.1%
FY2015Dec 31, 2015$81.76M+50.8%
FY2014Dec 31, 2014$54.20M+105.7%
FY2013Dec 31, 2013$26.35M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$39.55M-20.4%
Q2 FY2026Jun 30, 2026$42.21M-42.0%
Q1 FY2026Mar 31, 2026$45.13M+7.4%
Q4 FY2025Dec 31, 2025$49.22M-21.0%
Q3 FY2025Sep 30, 2025$49.67M+17.4%
Q2 FY2025Jun 30, 2025$72.74M+7.8%
Q1 FY2025Mar 31, 2025$42.02M-25.7%
Q4 FY2024Dec 31, 2024$62.31M-16.6%
Q3 FY2024Sep 30, 2024$42.30M-36.0%
Q2 FY2024Jun 30, 2024$67.49M-15.8%
Q1 FY2024Mar 31, 2024$56.52M-34.3%
Q4 FY2023Dec 31, 2023$74.71M-17.2%
Q3 FY2023Sep 30, 2023$66.06M-26.5%
Q2 FY2023Jun 30, 2023$80.17M-15.1%
Q1 FY2023Mar 31, 2023$85.98M-9.1%
Q4 FY2022Dec 31, 2022$90.25M-37.5%
Q3 FY2022Sep 30, 2022$89.88M-36.7%
Q2 FY2022Jun 30, 2022$94.44M-38.9%
Q1 FY2022Mar 31, 2022$94.63M-33.4%
Q4 FY2021Dec 31, 2021$144.49M-13.6%
Q3 FY2021Sep 30, 2021$142.04M-9.2%
Q2 FY2021Jun 30, 2021$154.49M+14.2%
Q1 FY2021Mar 31, 2021$142.17M-8.3%
Q4 FY2020Dec 31, 2020$167.25M+16.7%
Q3 FY2020Sep 30, 2020$156.50M+39.2%
Q2 FY2020Jun 30, 2020$135.32M+34.3%
Q1 FY2020Mar 31, 2020$154.99M+111.5%
Q4 FY2019Dec 31, 2019$143.28M+85.3%
Q3 FY2019Sep 30, 2019$112.41M+103.2%
Q2 FY2019Jun 30, 2019$100.79M+91.5%
Q1 FY2019Mar 31, 2019$73.28M+66.8%
Q4 FY2018Dec 31, 2018$77.33M+43.6%
Q3 FY2018Sep 30, 2018$55.32M+16.8%
Q2 FY2018Jun 30, 2018$52.64M+16.4%
Q1 FY2018Mar 31, 2018$43.92M+26.8%
Q4 FY2017Dec 31, 2017$53.87M+39.2%
Q3 FY2017Sep 30, 2017$47.36M–
Q2 FY2017Jun 30, 2017$45.24M–
Q1 FY2017Mar 31, 2017$34.64M–
Q4 FY2016Dec 31, 2016$38.70M–

More Amarin figures

See a number that looks wrong?